Integration of active tuberculosis case finding in a mobile HIV-testing clinic is feasible

A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa.

The study describes the integration of tuberculosis testing into a mobile HIV testing service for HIV-negative individuals with symptoms suggestive of tuberculosis and all HIV-positive individuals.

The mobile testing clinic, named the Tutu Tester after Archbishop Emeritus Desmond Tutu, visits underserviced areas in greater Cape Town and provides testing services for deprived communities.

The study demonstrates that active tuberculosis case finding in settings with a high burden of HIV and tuberculosis is feasible and has a high uptake, yield, and treatment success. However, the authors note that further work is required to determine whether mobile case finding is cost-effective and whether the service can be scaled up.

More information: Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, et al. (2012) Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study. PLoS Med 9(8): e1001281. doi:10.1371/journal.pmed.1001281

Related Stories

HIV/AIDS linked to drug resistant TB

date Nov 16, 2006

U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 9 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 19 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 19 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.